Assessing colorectal resections in patients with retroperitoneal sarcoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The COLOSARC-Q study is a multicenter observational project aimed at evaluating colorectal resections and reconstruction techniques during multivisceral resections for retroperitoneal sarcomas. It focuses on documenting surgical complications, such as anastomotic leakage rates and the incidence of stomas, while also assessing the impact of these procedures on patients' quality of life through standardized surveys. The study plans to include 120 patients who have undergone these surgeries at certified sarcoma centers, collecting detailed patient, tumor, and treatment-specific data. This comprehensive approach aims to enhance surgical decision-making and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Histological confirmation with evidence of a retroperitoneal sarcoma
* Tumor resection with colorectal resection
* Surgery in a DKG-certified sarcoma center or hospital that meets certification-equivalent criteria
* Age 18 years or older
* Written consent

Exclusion Criteria:

* Absence of consent

Where it's running

• Sarcoma Center of University Medical Center Mannheim
  Mannheim, Baden-Wurttemberg, Germany Recruiting
• University Medical Center Goettingen
  Göttingen, Deutschland, Germany Recruiting
• Helios Hospital Berlin-Buch
  Berlin, Germany Recruiting
• University Hospital Koeln
  Cologne, Germany Recruiting
• University Medical Center Dresden
  Dresden, Germany Recruiting
• University Medical Center Erlangen
  Erlangen, Germany Recruiting

Study contacts

• Principal investigator: Jens Jakob, Prof. — Sarcoma Unit, Department of Surgery, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
• Study coordinator: Jens Jakob, Prof.
• Email: Jens.Jakob@umm.de
• Phone: +49 621 383 2447

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Deep phenotyping of walking problems after lower-limb orthopedic surgery in children treated for cancer

  We will use motion-capture labs and wearable sensors to see how walking problems develop and change over time in children and teens (ages 5–20) who have lower-limb orthopedic surgery for bone or soft tissue sarcoma or steroid-induced avascular necrosis, and compare them to healthy peers.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07502885

• Personalised neoadjuvant therapy planning for adults with high‑risk soft tissue sarcoma

  This project tests whether analyzing tumor tissue and clinical data can help guide neoadjuvant chemotherapy decisions for adults with high‑risk soft tissue sarcomas.

  Recruiting Royal Marsden NHS Foundation Trust · London · NCT07432932

• Metformin plus standard first-line therapy for advanced soft tissue sarcoma

  This trial tests whether adding metformin to standard first-line systemic treatment helps people with previously untreated advanced or metastatic soft tissue sarcoma.

  Recruiting at 2 sites Phase 2 Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT07291297

• Short-course radiotherapy before surgery for soft tissue sarcoma

  This study tests whether a shorter course of radiation given before surgery (a 14 x 3 Gy schedule or an even shorter regimen) works as well and is safe for adults with intermediate- to high-grade soft tissue sarcoma.

  Recruiting at 2 sites The Netherlands Cancer Institute · Amsterdam and 5 other locations · NCT07071727

• Evaluating robotic rehabilitation and nutrition for patients with soft tissue sarcoma

  This study is testing if personalized robotic rehabilitation and nutrition support can help people with localized soft tissue sarcoma recover better after surgery and improve their quality of life.

  Recruiting Fondazione Policlinico Universitario Campus Bio-Medico · Rome, Lazio and 2 other locations · NCT06873685

• Short course radiation treatment for retroperitoneal sarcoma before surgery

  This study is testing a shorter radiation treatment for patients with retroperitoneal sarcoma to see if it can be safely used before surgery.

  Recruiting Phase 1 Brigham and Women's Hospital · Boston, Massachusetts · NCT06812052

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.